Literature DB >> 15972281

Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement.

P F Ferrucci, A Vanazzi, G Tesoriere, M Ferrari, M Bartolomei, P Rocca, M Cremonesi, G Paganelli, G Martinelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15972281     DOI： 10.1093/annonc/mdi305

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Authors:  Sofiane Maza; Philipp Kiewe; Dieter L Munz; Agnieszka Korfel; Bernd Hamm; Kristoph Jahnke; Eckhard Thiel
Journal:  Neuro Oncol       Date:  2008-12-05       Impact factor: 12.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.